Search

Author/Creator Steinhart, Hillary

1. Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease. Issue 11 (18th October 2019)

Authors:
Turpin, Williams; Espin-Garcia, Osvaldo; Bedrani, Larbi; Madsen, Karen; Meddings, Jonathan B; Raygoza Garay, Juan Antonio; Silverberg, Mark S; Smith, Michelle I; Griffiths, Anne M; Moayyedi, Paul; Marshall, John K; Mack, David; Seidman, Ernest G; Ropeleski, Mark; Feagan, Brian G; Jacobson, Kevan;...
Journal:
Inflammatory bowel diseases
Issue:
Volume 25:Issue 11(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease. (1st August 2004)

Authors:
Panaccione, Remo; Fedorak, Richard N; Anmais, Guy; Bernstein, Charles N; Bitton, Alain; Croitoru, Ken; Enns, Robert; Feagan, Brian; Fishman, Marty; Greenberg, Gordon; Griffiths, Anne; Marshall, John K; Rasul, Imran; Sadowski, Daniel; Seidman, Ernest; Steinhart, Hillary; Sutherland, Lloyd; Walli, ...
Journal:
Canadian Journal of Gastroenterology
Issue:
Volume 18:Number 8(2004)
Page Start:
503
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

Authors:
Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J; Aguilar, Humberto; Ah...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 2(2022)
Page Start:
128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study. (January 2022)

Authors:
Vermeire, Severine; Lakatos, Peter L; Ritter, Timothy; Hanauer, Stephen; Bressler, Brian; Khanna, Reena; Isaacs, Kim; Shah, Saumin; Kadva, Alysha; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Eden, Christopher; Zhang, Wenhui; Feagan, Brian G; Abraham, Philip; Acir Crip...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 1(2022)
Page Start:
28
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. FUT2 genotype and secretory status are not associated with fecal microbial composition and inferred function in healthy subjects. (4th July 2018)

Authors:
Turpin, Williams; Bedrani, Larbi; Espin-Garcia, Osvaldo; Xu, Wei; Silverberg, Mark S.; Smith, Michelle I.; Guttman, David S.; Griffiths, Anne; Moayyedi, Paul; Panaccione, Remo; Huynh, Hien; Steinhart, Hillary; Aumais, Guy; Shestopaloff, Konstantin; Dieleman, Levinus A.; Turner, Dan; Paterson, And...
Journal:
Gut microbes
Issue:
Volume 9:Isuse 4(2018)
Page Start:
357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗